共 78 条
- [1] Koh AH(2013)Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment Retina 33 686-716
- [2] Expert PCVP(1990)Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1-8
- [3] Chen LJ(2010)Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration Graefe’s Arch Clin Exp Ophthalmol 248 361-8
- [4] Yannuzzi LA(2009)Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 116 2400-6
- [5] Sorenson J(2003)Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics Arch Ophthalmol 121 1392-6
- [6] Spaide RF(1997)The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 115 478-85
- [7] Maruko I(2012)EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy Retina 32 1453-64
- [8] Iida T(2007)Role of photodynamic therapy in polypoidal choroidal vasculopathy Jpn J Ophthalmol 51 270-7
- [9] Saito M(2008)Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence Jpn J Ophthalmol 52 108-15
- [10] Ueta T(2004)Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy Am J Ophthalmol 137 826-33